PROTHENA CORP PUBLIC LTD CO (PRTA) Financials
Annual revenue, profitability and per-share results for PROTHENA CORP PUBLIC LTD CO, as reported in SEC filings.
Revenue • FY2025
$9.68M
▼ 92.8%YoY
Net income • FY2025
-$244.09M
▼ 99.6%YoY
Diluted EPS • FY2025
-$4.53
▼ 99.6%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $9.68M | -$244.09M | — | -$4.53 | — | -2216.4% | -92.8% |
| FY2024 | $135.16M | -$122.31M | — | -$2.27 | — | -114.4% | +47.9% |
| FY2023 | $91.37M | -$147.03M | — | -$2.76 | — | -209.1% | +69.5% |
| FY2022 | $53.91M | -$116.95M | — | -$2.47 | — | -244.1% | -73.1% |
Figures as reported in PROTHENA CORP PUBLIC LTD CO's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a PRTA filing.
Get an email when PRTA files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.